ARCHIVES

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center

December 11, 1998

NCI Clamps Down On Site Visits, Announces New Policy To Reduce Number, Improve Quality

April 26, 1974

Report Tells NCI to Increase Funding for SPOREs.

June 30, 2006

NIEHS, Five Grantees Form Toxicogenomics Group.

November 16, 2001

In Brief: National Patient Advocates Foundation Formed To Seek Health Insurance Reform

November 15, 1996

In Brief: Congress Working On Interim Financing Measure to Fund Agencies, Including NCI, Through Election

September 26, 1980